Flyer

Journal of Universal Surgery

  • ISSN: 2254-6758
  • Journal h-index: 6
  • Journal CiteScore: 0.94
  • Journal Impact Factor: 0.82
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Genamics JournalSeek
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Euro Pub
  • Google Scholar
  • J-Gate
  • SHERPA ROMEO
  • International Committee of Medical Journal Editors (ICMJE)
  • Zenodo
Share This Page

Pancreatic cancer threat: Do we have a chance for the future?

Joint Event on 3rd European Conference on Surgery, Plastic Reconstructive & Aesthetic Surgery
March 25-26, 2019 | Budapest, Hungary

Ryska M

Charles University,Czech Republic

Scientific Tracks Abstracts: J Univer Surg

Abstract:

Ductal adenocarcinoma of the pancreas is currently a major health problem in so-called developed countries. Our population reaches the first place in incidence in Europe in the last statistics, which will double by 2030. Radical resection, in combination with adjuvant chemotherapy, is the only treatment with curative intent. Significant disease progression at the first symptoms of the disease results in poor treatment success. It is therefore very important to follow the rational diagnostic and therapeutic procedure and to include as soon as possible the patient's multidisciplinary team into a suitable group: primary resectable, borderline resectable, non-resectable (locally advanced or metastatic) and to initiate adequate therapy. The second purpose of the present communication is to introduce the reader to the likely attitude of the patient present at different stages of the disease and the treatment groups.

Biography :

After Faculty of Medicine in 1978 he joined as an internal aspirant at the Surgical Clinic of the Faculty Hospital in Prague, in 1984 he worked for 4 months at the Surgical Clinic in Uppsala, Sweden, and from 1984 until 1992, a clinic assistant. In 1991 he graduated from a postgraduate surgical school at Hammersmith Hospital in London. In 1992 he habilitated from surgery (Friedly surgery in the treatment of choledocholithiasis) and until 1994 he worked as an assistant professor of surgery at the Surgical Clinic of the 3rd Medical Faculty of Charles University). In 1994 he joined the IKEM Cardiovascular and Transplantation Surgery Clinic and after completing a four-month internship at the Virchow University Surgical Clinic in Berlin under Prof. P. Neuhause started a liver transplant program at IKEM. In 1997 and 1998, he completed his monthly study stays in Mt. Sinai Hospital in New York and UCLA in Los Angeles. In 1998 he founded the IKEM Transplantation Surgery Clinic, where he worked as its head until 2004. Since 2004, when he was appointed Professor of Surgery, in 2005 he founded the Surgical Clinic of the 2nd Medical Faculty of the Charles University and the University Hospital Prague. For 4 months he was the Chief Medical Officer of the 6th Army Hospital of the Czech Army in Kabul (2008). Since 1 July 2010 he has served as Deputy Director of the Prague National Institute for Science and Education. From 12/2011 to 7/2014 he was a member of the Government Council for Science, Research and Innovation. From 1.4. 2014 is the chair of the newly established Agency for Health Research.

E-mail: miroslav.ryska@uvn.cz